These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 18951953)
1. Hippocampal neuronal subpopulations are differentially affected in double transgenic mice overexpressing frontotemporal dementia and parkinsonism linked to chromosome 17 tau and glycogen synthase kinase-3beta. Engel T; Goñi-Oliver P; Gomez-Ramos P; Morán MA; Lucas JJ; Avila J; Hernández F Neuroscience; 2008 Dec; 157(4):772-80. PubMed ID: 18951953 [TBL] [Abstract][Full Text] [Related]
2. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert. Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563 [TBL] [Abstract][Full Text] [Related]
3. GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease: involvement of astrocyte-neuron interactions. L'Episcopo F; Drouin-Ouellet J; Tirolo C; Pulvirenti A; Giugno R; Testa N; Caniglia S; Serapide MF; Cisbani G; Barker RA; Cicchetti F; Marchetti B Cell Death Dis; 2016 Apr; 7(4):e2206. PubMed ID: 27124580 [TBL] [Abstract][Full Text] [Related]
4. Cooexpression of FTDP-17 tau and GSK-3beta in transgenic mice induce tau polymerization and neurodegeneration. Engel T; Lucas JJ; Gómez-Ramos P; Moran MA; Avila J; Hernández F Neurobiol Aging; 2006 Sep; 27(9):1258-68. PubMed ID: 16054268 [TBL] [Abstract][Full Text] [Related]
5. A mouse model to study tau pathology related with tau phosphorylation and assembly. Engel T; Lucas JJ; Hernández F; Avila J J Neurol Sci; 2007 Jun; 257(1-2):250-4. PubMed ID: 17362999 [TBL] [Abstract][Full Text] [Related]
6. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. Lucas JJ; Hernández F; Gómez-Ramos P; Morán MA; Hen R; Avila J EMBO J; 2001 Jan; 20(1-2):27-39. PubMed ID: 11226152 [TBL] [Abstract][Full Text] [Related]
7. Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models. Duka T; Duka V; Joyce JN; Sidhu A FASEB J; 2009 Sep; 23(9):2820-30. PubMed ID: 19369384 [TBL] [Abstract][Full Text] [Related]
8. Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta. Kitazawa M; Trinh DN; LaFerla FM Ann Neurol; 2008 Jul; 64(1):15-24. PubMed ID: 18318434 [TBL] [Abstract][Full Text] [Related]
10. Suppression of Parkin enhances nigrostriatal and motor neuron lesion in mice over-expressing human-mutated tau protein. Menéndez J; Rodríguez-Navarro JA; Solano RM; Casarejos MJ; Rodal I; Guerrero R; Sánchez MP; Avila J; Mena MA; de Yébenes JG Hum Mol Genet; 2006 Jul; 15(13):2045-58. PubMed ID: 16698879 [TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379 [TBL] [Abstract][Full Text] [Related]
12. Tau kinase I overexpression induces dentate gyrus degeneration. Avila J; Gómez de Barreda E; Engel T; Pérez M; Martín-Maestro P; Fuster-Matanzo A; Goñi-Oliver P; Lucas JJ; Hernández F Neurodegener Dis; 2010; 7(1-3):13-5. PubMed ID: 20160451 [TBL] [Abstract][Full Text] [Related]
13. Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease. Haggerty T; Credle J; Rodriguez O; Wills J; Oaks AW; Masliah E; Sidhu A Eur J Neurosci; 2011 May; 33(9):1598-610. PubMed ID: 21453448 [TBL] [Abstract][Full Text] [Related]
14. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance. Jiang T; Yu JT; Zhu XC; Zhang QQ; Cao L; Wang HF; Tan MS; Gao Q; Qin H; Zhang YD; Tan L Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087 [TBL] [Abstract][Full Text] [Related]
15. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease. Saul A; Sprenger F; Bayer TA; Wirths O Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045 [TBL] [Abstract][Full Text] [Related]
16. GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein. Credle JJ; George JL; Wills J; Duka V; Shah K; Lee YC; Rodriguez O; Simkins T; Winter M; Moechars D; Steckler T; Goudreau J; Finkelstein DI; Sidhu A Cell Death Differ; 2015 May; 22(5):838-51. PubMed ID: 25394490 [TBL] [Abstract][Full Text] [Related]
17. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons. Takahashi M; Yasutake K; Tomizawa K J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067 [TBL] [Abstract][Full Text] [Related]
18. Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits. Gómez de Barreda E; Pérez M; Gómez Ramos P; de Cristobal J; Martín-Maestro P; Morán A; Dawson HN; Vitek MP; Lucas JJ; Hernández F; Avila J Neurobiol Dis; 2010 Mar; 37(3):622-9. PubMed ID: 20004245 [TBL] [Abstract][Full Text] [Related]
19. Tau overexpression inhibits cell apoptosis with the mechanisms involving multiple viability-related factors. Wang HH; Li HL; Liu R; Zhang Y; Liao K; Wang Q; Wang JZ; Liu SJ J Alzheimers Dis; 2010; 21(1):167-79. PubMed ID: 20413892 [TBL] [Abstract][Full Text] [Related]
20. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]